Discontinuing antidepressants: Pearls and pitfalls

15Citations
Citations of this article
42Readers
Mendeley users who have this article in their library.

Abstract

Stopping antidepressants can be challenging due to the high rate of discontinuation symptoms. Patients with antidepressant discontinuation syndrome (ADS) commonly experience insomnia, flu-like symptoms, mood disturbances, dizziness, and paresthesias, but a broad array of adverse effects is possible. Symptoms can last for days to months, and different symptoms have different durations. Patient education, identification of patients most at risk for developing symptoms, and a slow antidepressant taper or crosstaper are important steps in mitigating the risk of ADS and managing patient concerns about ADS. Tapers should be carried out over weeks to months. Discontinuation symptoms should be managed with restarting the prior dose of antidepressant and then tapering even more slowly, with additional symptomatic management as needed.

Cite

CITATION STYLE

APA

Zwiebel, S. J., & Viguera, A. C. (2022). Discontinuing antidepressants: Pearls and pitfalls. Cleveland Clinic Journal of Medicine, 89(1), 18–26. https://doi.org/10.3949/ccjm.89a.21020

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free